AQR Arbitrage’s Verona Pharma VRNA Stock Holding History

AQR Arbitrage’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-513,778	Closed	-$54.8M	–	548
2025 Q3	$54.8M	Buy	+513,778	New	+$53.6M	1.39%	13

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

AQR Arbitrage's VRNA Position: Q4 2025 in Review

AQR Arbitrage sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 513,778 shares — an estimated $54.8M sold.

AQR Arbitrage first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $54.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

AQR Arbitrage reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
AQR Arbitrage sold 513,778 Verona Pharma shares in Q4 2025, an estimated $54.8M.
AQR Arbitrage first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
AQR Arbitrage's Verona Pharma position peaked at $54.8M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on AQR Arbitrage's 13F filing for Q4 2025, filed 17 Feb 2026.